Apart from the vaccine offering the convenience of a single shot, it will also allow governments to slash costs for staffing and operations related to the second doses
Darrell Gaskin, a health policy professor at Johns Hopkins University, in Clinton, Md., Feb. 25, 2021.
Johnson & Johnson’s one-shot vaccine is allowing states to rethink distribution, even as health officials and experts worry some will view it as inferior.
Image: Valerie Plesch/The New York Times
©2019 New York Times News Service